US authorities will halt production of the British-Swedish company AstraZeneca’s coronavirus vaccine at its Emergent Biosolutions plant in Baltimore, Maryland. The administration made the corresponding decision of American President Joe Biden, The New York Times reports.
The plant will continue to manufacture the drug by the American Johnson & Johnson, with the help of which the United States wants to accelerate the country’s pace of vaccination.
AstraZeneca is in talks to find a new vaccine production site in the United States. The plant representative clarified that the production of the drug would not be stopped until the company receives a modified version of the contract.
The authorities made such a decision after 15 million doses of the Johnson & Johnson vaccine were spoiled due to mixing the ingredients of the two manufacturers’ drugs by mistake. Employees of the American Johnson & Johnson plant in Baltimore made a mistake when mixing the coronavirus vaccine ingredients, which led to the loss of 15 million doses of the drug. Because of the incident, the FDA is inspecting the plant.
Several European countries have suspended or banned vaccination with AstraZeneca due to the detection of thrombosis in vaccinated patients. Meanwhile, the creators of the vaccine insist on its safety. The company said that a detailed study of more than 17 million people’s health status after vaccination showed no data on an increased risk of pulmonary embolism, deep vein thrombosis or thrombocytopenia. The European Medicines Agency (EMA) also stated that there was no reason to refuse this vaccine.